A real world data of RENFLEXIS (infliximab-abda) in patients with Inflammatory Bowel Disease (IBD)
Latest Information Update: 30 Oct 2020
At a glance
- Drugs Infliximab (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- 30 Oct 2020 New trial record
- 26 Oct 2020 According to a Samsung Bioepis media release, Nabeel Khan, MD, Associate Professor of Clinical Medicine, University of Pennsylvania, led this study.
- 26 Oct 2020 According to a Samsung Bioepis media release, data from this were presented at the American College of Gastroenterology (ACG) 2020 Annual Scientific Meeting.